Ulcerative colitis: open trials in Argentina

9 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Stat Research S.A., Buenos Aires · GEDYT, Buenos Aires · Mautalen Salud e Investigación, Buenos Aires · Sanatorio Maipú, Mendoza · CER medical Institute, Quilmes · Hospital Provincial del Centenario, Rosario · INECO Neurociencias Oroño, Rosario · Instituto Médico de Alta Complejidad San Isidro Sa, San Isidro · C.I.C.E. 9 de Julio, San Miguel de Tucumán
Registry updated 2026-11-04
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Instituto CAICI, Rosario
Registry updated 2026-11-03
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Instituto Medico De Alta Complejidad (IMAC), Buenos Aires · GEDYT, Famailla · Globalpsy, La Plata · HIGEA, Mendoza · Instituto De Investigaciones Clinicas Quilmes, Quilmes · Hospital Provincial del Centenario, Rosario · MR Medicina Reumatologica, San Fernando
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Lujan de Cuyo · Rosario
Registry updated 2026-11-03
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial Treatment · Phase 1/2 · Xencor, Inc.
Buenos Aires · Rosario · San Miguel de Tucumán
Registry updated 2026-10-30
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
La Plata · Lujan de Cuyo · Rosario · San Miguel de Tucumán
Registry updated 2026-10-27
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Córdoba
Registry updated 2026-10-23
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Rosario
Registry updated 2026-10-16
NCT07155148
Argentine Registry of Crohn's Disease and Ulcerative Colitis
Research · Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa
Hospital Privado Universitario de Córdoba, Córdoba
Registry updated 2025-09-23

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error